Healthcare ❯Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Alzheimer's Disease Oncology Drugs Obesity Drugs Pipeline Generic Drugs Market Trends Immunology COVID-19 Vaccines Market Competition Investigational Drugs Manufacturing Pfizer Inc. OXBRYTA Multiple Sclerosis Treatments Monoclonal Antibodies Diabetes Treatment Weight-loss Drugs Mental Health Treatments Mental Health Drugs Antibiotics Marine Drugs Esketamine FDA Regulations Covid Products Chronic Disease Management Research Centers Lenacapavir Rare Diseases Neurological Conditions Drug Failure Heart Disease Next-Generation Drugs ALS Drug Development Regulatory Agencies Pain Signaling Alzheimer's Drug Obesity Drug Discontinued Drug Obesity Treatment Imdelltra Weight-Loss Drugs Psychedelics Alzheimer's Treatment Formulation Weight Loss Treatments Market Performance Treatment Options Mental Health Brain Health Antibody Drug Conjugates Clinical Research

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

Eli Lilly Sues Strive and Empower Over Unapproved Tirzepatide Products

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

UNAIDS Warns of Global HIV/AIDS Crisis Following US Aid Freeze

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Ebola Pill Shows Promise in Monkey Trials, Raising Hopes for Human Treatment

Debate Grows Over Proposed Polypill for Preventing Heart Disease in Over-50s

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

Eli Lilly Reports Mixed Q4 Results as Key Drug Sales Fall Short of Expectations

Merck Cuts 2025 Revenue Forecast After Halting Gardasil Shipments to China

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts

Johnson & Johnson Exceeds Q4 Expectations with Strong Cancer Drug Sales

Oyster Blood Shows Potential in Combating Antibiotic-Resistant Superbugs

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Lenacapavir Injection Offers Breakthrough in HIV Prevention

First New Asthma and COPD Treatment in 50 Years Shows Promise

AstraZeneca Shares Plummet Amid Expanding China Fraud Investigation

New Schizophrenia Drug Cobenfy Shows Mixed Results in Trials

EU Fines Teva $503 Million for Blocking MS Drug Competition

Eli Lilly Shares Plunge After Disappointing Q3 Earnings and Sales

Biogen Boosts Profit Forecast as Alzheimer's Drug Leqembi Gains Traction

Pfizer Faces Activist Pressure as Ex-Execs Withdraw Support for Starboard

Starboard Value Acquires $1 Billion Stake in Pfizer

Eli Lilly to Invest $4.5 Billion in New Indiana Drug Manufacturing Facility

FDA Approves First New Schizophrenia Drug in Decades

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

Weight-Loss Drug Tirzepatide More Effective in Women, Study Finds

AstraZeneca Under Chinese Compliance Probe; Lung Cancer Drug Trial Results Disappoint

Eli Lilly Names Lucas Montarce as New CFO Amid Expansion Efforts

Biogen Raises 2024 Profit Forecast Following Strong Q2 Earnings

Kim Jong Un's Health Worsens as Succession Plans Emerge

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts

Bristol Myers Squibb Surges on Strong Q2 Performance and Raised Guidance

New HIV Prevention Drug Shows 100% Efficacy in Women

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Roche's New Weight Loss Pill Shakes Up Pharmaceutical Market

Pfizer Advances Daily Weight Loss Pill Amid FDA Rejection of Novo's Insulin

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock

Weight-Loss Drug Tirzepatide Shows Promise for Treating Sleep Apnea

Insmed's Experimental Drug Brensocatib Achieves Major Trial Success

Biogen Acquires HI-Bio for $1.15 Billion to Enhance Immunology Pipeline

AstraZeneca Targets $80 Billion Revenue by 2030 with 20 New Medicines

Weight-Loss Drug Market Heats Up as Prices Drop and New Treatments Emerge

Biogen's Alzheimer's Drug Leqembi Exceeds Sales Expectations

EU Regulators Clear Ozempic and Related Drugs of Suicidal Thoughts Link

Amylyx Withdraws ALS Drug Relyvrio After Failing Key Study

Novo Nordisk Acquires Cardior Pharmaceuticals for $1.1 Billion

ALS Drug Relyvrio Fails Key Clinical Trial, May Be Pulled from Market

GSK Acquires Bellus Health for $2 billion, Gaining Control of Experimental Cough Medicine